ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Net margin 2022–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) net profit margin by fiscal year — reported net income divided by reported revenue.
-4.3%FY2025 · since FY2022: -8449.8% → -4.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4.3% | +67.0 pp |
| FY2024 | -71.3% | +368.5 pp |
| FY2023 | -439.8% | +8010.0 pp |
| FY2022 | -8449.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice